Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronidase as Adjuvant to Bupivacaine in TAB Block for Cesarean Section
NCT06839391Phase 1Not yet recruiting
- Sponsor
- Benha University
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Modality
- Therapeutic Enzymes
01
Overview
Phase 1, randomised, double-blind trial of hyaluronidase in postoperative pain (3 arms), sponsored by Benha University. Primary endpoints: Duration of sensory block and Visual Analogue Scale. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
hyaluronidase
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06839391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06839391.